Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm - PubMed (original) (raw)
Review
Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm
Polliana Mihaela Leru. Clin Transl Allergy. 2019.
Abstract
Eosinophilic disorders represent a group of pathologic conditions with highly heterogeneous pathophysiology and clinical presentation and variable prognosis, ranging from asymptomatic or mild, to severe and complex cases, with fatal outcome. Interest in this group of disorders has increased during the last two decades, with consistent progress made regarding understanding of molecular mechanisms, refining of diagnostic criteria, classification and evaluation of therapeutic options. There are still many gaps and difficulties in evaluating eosinophilic syndromes and diseases in medical practice. The disease prognosis depends mainly on the cause and mechanism of eosinophilia, on severity of organ dysfunction and on accurate diagnosis and response to treatment. Besides primary hypereosinophilic syndromes and secondary (reactive) eosinophilias, many associated or idiopathic forms have been described, making this topic a complex and difficult medical entity. An important aim of the experts in the field is to agree upon a more clear and practically useful classification, a better characterization of various phenotypes and endotypes of eosinophilic diseases and to identify novel biomarkers and more effective therapies. The aim of this paper is to review recent data from the literature regarding definition, classification and diagnosis criteria of eosinophilic diseases and to propose a revised and updated diagnostic algorithm useful in clinical practice.
Keywords: Diagnostic criteria; Eosinophilic disorders; Hypereosinophilia; Hypereosinophilic syndrome; Practical diagnostic algorithm.
Conflict of interest statement
Competing interestsThe author declares no conflict of interest in relation with this manuscript.
Figures
Fig. 1
A proposed diagnostic algorithm of Hypereosinophilia and Eosinophilic diseases
Similar articles
- Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.
Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, Butterfield JH, Sperr WR, Sotlar K, Vandenberghe P, Haferlach T, Simon HU, Reiter A, Gleich GJ. Valent P, et al. J Allergy Clin Immunol. 2012 Sep;130(3):607-612.e9. doi: 10.1016/j.jaci.2012.02.019. Epub 2012 Mar 28. J Allergy Clin Immunol. 2012. PMID: 22460074 Free PMC article. - (A Critical Appraisal of) Classification of Hypereosinophilic Disorders.
Kahn JE, Groh M, Lefèvre G. Kahn JE, et al. Front Med (Lausanne). 2017 Dec 5;4:216. doi: 10.3389/fmed.2017.00216. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29259972 Free PMC article. Review. - [Hypereosinophilia of the blood. II. Classification. Benign essential hypereosinophilia. Eosinophilia caused by systemic eosinophilic hemopathies].
Lovisetto P, Manachino D, Biarese V, Marchi L, Andrione P. Lovisetto P, et al. Minerva Med. 1985 May 31;76(22-23):1049-53. Minerva Med. 1985. PMID: 4011004 Italian. - World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J. Gotlib J. Am J Hematol. 2011 Aug;86(8):677-88. doi: 10.1002/ajh.22062. Am J Hematol. 2011. PMID: 21761433 Review.
Cited by
- Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report.
Trave I, Salvi I, Bagnasco D, Parodi A, Cozzani E. Trave I, et al. Acta Derm Venereol. 2024 Sep 19;104:adv40800. doi: 10.2340/actadv.v104.40800. Acta Derm Venereol. 2024. PMID: 39295583 Free PMC article. No abstract available. - Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach.
Caminati M, Carpagnano LF, Alberti C, Amaddeo F, Bixio R, Caldart F, De Franceschi L, Del Giglio M, Festi G, Friso S, Frulloni L, Gisondi P, Krampera M, Lippi G, Micheletto C, Piacentini G, Pinter P, Rossini M, Schiappoli M, Tecchio C, Tenero L, Tinazzi E, Senna G, Carlucci M; Multidisciplinary Group on rare dysimmune conditions with hyper-Eosinophilia (GEos). Caminati M, et al. World Allergy Organ J. 2024 Jul 25;17(8):100928. doi: 10.1016/j.waojou.2024.100928. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39156600 Free PMC article. Review. - Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).
Caminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano LF, Caruso C, Cosmi L, D'Amore S, Del Giacco S, Detoraki A, Di Gioacchino M, Matucci A, Mormile I, Granata F, Guarnieri G, Krampera M, Maule M, Nettis E, Nicola S, Noviello S, Pane F, Papayannidis C, Parronchi P, Pelaia G, Ridolo E, Rossi FW, Senna G, Triggiani M, Vacca A, Vivarelli E, Vultaggio A, de Paulis A. Caminati M, et al. Cells. 2024 Jul 11;13(14):1180. doi: 10.3390/cells13141180. Cells. 2024. PMID: 39056762 Free PMC article. Review. - Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.
Saelue P, Sinthujaroen P, Suwiwat S, Thongsuksai P. Saelue P, et al. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241263099. doi: 10.1177/10760296241263099. Clin Appl Thromb Hemost. 2024. PMID: 39053144 Free PMC article. - Concurrent Challenges in Idiopathic Hypereosinophilic Syndrome Complicating Beta-Thalassemia Major: A Case Report.
Daiya V, Kumar S, Acharya S, Pradeep U, Jaiswal S. Daiya V, et al. Cureus. 2024 Mar 14;16(3):e56199. doi: 10.7759/cureus.56199. eCollection 2024 Mar. Cureus. 2024. PMID: 38618303 Free PMC article.
References
- Sreedharanunni S, Varma N, Sachdeva MUS, Naseem S, Malhotra P, Bansal D, Trehan A, Varma S. The spectrum of hypereosinophilia and associated clonal disorders—a real-world data based on combined retrospective and prospective analysis from a tropical setting. Mediterr J Hematol Infect Dis. 2018;10(1):e2018052. doi: 10.4084/MJHID.2018.052. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources